Development of In Situ Gelling Meloxicam-Human Serum Albumin Nanoparticle Formulation for Nose-to-Brain Application

The aim of this study was to develop an intranasal in situ thermo-gelling meloxicam-human serum albumin (MEL-HSA) nanoparticulate formulation applying poloxamer 407 (P407), which can be administered in liquid state into the nostril, and to increase the resistance of the formulation against mucocilia...

Descripción completa

Detalles Bibliográficos
Autores principales: Katona, Gábor, Sipos, Bence, Budai-Szűcs, Mária, Balogh, György Tibor, Veszelka, Szilvia, Gróf, Ilona, Deli, Mária A., Volk, Balázs, Szabó-Révész, Piroska, Csóka, Ildikó
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147280/
https://www.ncbi.nlm.nih.gov/pubmed/34062873
http://dx.doi.org/10.3390/pharmaceutics13050646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147280/
https://www.ncbi.nlm.nih.gov/pubmed/34062873
http://dx.doi.org/10.3390/pharmaceutics13050646

Ejemplares similares